Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yongjune Lee"'
Autor:
Hyung-Don Kim, Hyehyun Jeong, Jae-Lyun Lee, Kye Jin Park, J.H. Kim, Bumsik Hong, Yongjune Lee, Shinkyo Yoon
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose This study aims to evaluate the prognosis of pathologically node-positive bladder cancer after neoadjuvant chemotherapy, the role of adjuvant chemotherapy in these patients, and the value of preoperative clinical evaluation for lymph node met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f458326d0729b81244e9c75c5cca9ad7
https://doi.org/10.4143/crt.2021.365
https://doi.org/10.4143/crt.2021.365
Autor:
J.H. Kim, Yangsoon Park, Moon-Won Yoo, Hyungwoo Cho, Yongjune Lee, Ki-Hun Kim, Yoon-Koo Kang, Young Soo Park, Sun-Mi Lee, Beom Soo Kim, Min-Hee Ryu, Chan Wook Kim
Publikováno v:
The Oncologist
This article compares clinical outcomes of two groups of patients with advanced gastrointestinal stromal tumors: patients who underwent resection plus imatinib dose escalation or maintenance and patients who were treated with imatinib dose escalation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c664c215e7dd9873d6d601e6694263cf
https://doi.org/10.1634/theoncologist.2019-0009
https://doi.org/10.1634/theoncologist.2019-0009
Autor:
양석균 ( Suk-kyun Yang ), 현동곤 ( Dong-gon Hyun ), 김혜영 ( Hye Yeong Kim ), 김소현 ( So Hyun Kim ), 김용길 ( Yong-gil Kim ), 최수진 ( Su Jin Choi ), 이용준 ( Yongjune Lee )
Publikováno v:
The Korean Journal of Medicine. 94:303-307
TNF 억제제는 만성 염증성 질환에서 널리 사용되는 약제로, 드물지만 TNF 억제제 유발 루푸스를 일으킬 수 있다. 이는 일반적인 약제 유발 루푸스와는 다르게 피부 증상, 관절염 증상이 흔하
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f4cd064f5379ec3b9970db6f0d6b267
https://doi.org/10.3904/kjm.2019.94.3.303
https://doi.org/10.3904/kjm.2019.94.3.303
PurposeTo compare the efficacy and safety of high dose-intensity combination of methotrexate, vinblastine, adriamycin and cisplatin (HD MVAC) with gemcitabine plus cisplatin (GC) as a neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15ffa5d355202f84c72c9feaafa202b8
https://doi.org/10.21203/rs.3.rs-164451/v1
https://doi.org/10.21203/rs.3.rs-164451/v1
Autor:
Hyehyun Jeong, Kye Jin Park, Yongjune Lee, Hyung-Don Kim, Jwa Hoon Kim, Shinkyo Yoon, Bumsik Hong, Jae Lyun Lee
Publikováno v:
Cancer Research & Treatment; Jan2022, Vol. 54 Issue 1, p226-233, 8p
Publikováno v:
Journal of Clinical Oncology. 37:375-375
375 Background: Efficacy of cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) for T2-4aN1M0 muscle-invasive bladder cancer (MIBC) was proved by randomize controlled trials. Recent retrospective studies suggested that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5574f5850b189c6c65620780218bdf3c
https://doi.org/10.1200/jco.2019.37.7_suppl.375
https://doi.org/10.1200/jco.2019.37.7_suppl.375
Publikováno v:
Journal of Clinical Oncology. 37:376-376
376 Background: Prospective randomized trials demonstrated efficacy of MVAC (Methotrexate, Vinblastine, Doxorubicin, Cisplatin) neoadjuvant chemotherapy (NAC) in muscle invasive bladder cancer (MIBC). In metastatic setting urothelial cell carcinoma (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f02715a9df35ccfa25188eb60ad947f
https://doi.org/10.1200/jco.2019.37.7_suppl.376
https://doi.org/10.1200/jco.2019.37.7_suppl.376